Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for IM Cannabis (IMCC) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • IM Cannabis' Total Non-Current Liabilities rose 3218.93% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 3218.93%. This contributed to the annual value of $820969.0 for FY2024, which is 5113.93% down from last year.
  • Per IM Cannabis' latest filing, its Total Non-Current Liabilities stood at $1.1 million for Q3 2025, which was up 3218.93% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Total Non-Current Liabilities registered a high of $24.4 million during Q3 2021, and its lowest value of $673918.2 during Q1 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $2.3 million (2022), whereas its average is $6.2 million.
  • In the last 5 years, IM Cannabis' Total Non-Current Liabilities tumbled by 8788.46% in 2022 and then surged by 3791.31% in 2025.
  • Quarter analysis of 5 years shows IM Cannabis' Total Non-Current Liabilities stood at $15.0 million in 2021, then crashed by 85.0% to $2.3 million in 2022, then fell by 26.13% to $1.7 million in 2023, then tumbled by 51.68% to $804614.5 in 2024, then skyrocketed by 41.75% to $1.1 million in 2025.
  • Its Total Non-Current Liabilities was $1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and $673918.2 in Q1 2025.